Correlation Between Ocean Biomedical and Crispr Therapeutics

Can any of the company-specific risk be diversified away by investing in both Ocean Biomedical and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocean Biomedical and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ocean Biomedical and Crispr Therapeutics AG, you can compare the effects of market volatilities on Ocean Biomedical and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocean Biomedical with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocean Biomedical and Crispr Therapeutics.

Diversification Opportunities for Ocean Biomedical and Crispr Therapeutics

0.09

Correlation Coefficient

Ocean Biomedical  Crispr Therapeutics

Significant diversification

The 3 months correlation between Ocean and Crispr is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Ocean Biomedical and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Ocean Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocean Biomedical are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Ocean Biomedical i.e., Ocean Biomedical and Crispr Therapeutics go up and down completely randomly.

Pair Corralation between Ocean Biomedical and Crispr Therapeutics

Given the investment horizon of 90 days Ocean Biomedical is expected to generate 4.81 times more return on investment than Crispr Therapeutics. However, Ocean Biomedical is 4.81 times more volatile than Crispr Therapeutics AG. It trades about 0.05 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about -0.05 per unit of risk. If you would invest  62.00  in Ocean Biomedical on September 25, 2024 and sell it today you would earn a total of  2.00  from holding Ocean Biomedical or generate 3.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ocean Biomedical  vs.  Crispr Therapeutics AG

Ocean Biomedical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ocean Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Crispr Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Crispr Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unfluctuating performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with Ocean Biomedical and Crispr Therapeutics

The main advantage of trading using opposite Ocean Biomedical and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocean Biomedical position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.

The idea behind Ocean Biomedical and Crispr Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.